Chapter 182: Price revealed, netizens vomiting blood.

Now as they are against modifying their own genes, the 'EBT-002 Gene Medical Drug' is divided into two versions.

The original 'EBT-002 gene medical drug' has doubled in price by yuan, which also means that if they want to gain lifelong immunity to AIDS, they need to pay twice as much.

Faced with this situation, how could those AIDS patients not be so angry that they vomit blood?
At this point they just wanted to curse, want to know who was against modifying their own genes, and then beat him up.

As for why Xingtu Fund Company developed two versions of "EBT-002 Gene Medical Drug"?
The reason was that the West had developed its own AIDS specific drug, 'Bode-001 AIDS specific drug', and at this time Starway Gene Company produced two versions in order to respond to the challenge.

The purpose is to overcome the impact of 'Bode-001 AIDS specific drug', directly compete with them in a differentiated way, and maintain its own high profits.

From now on, the 'EBT-002 Gene Medical Drug' that does not modify the human gene version and the 'Bode-001 AIDS Specific Drug' will face off against each other, and their prices will be similar in the future.

The lifelong immunity version that provides lifelong immunity to HIV will be in a superior position. With a higher price, even if the number of injections is small, the actual profit will be higher.

As for whether they object, opponents can simply purchase the non-gene-modifying version of 'EBT-002 Gene Medical Drug'.

Of course, what AIDS patients are thinking is not of concern to Lu Shouyi, a dying hepatitis B patient.

When he heard that 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' could kill all known types of hepatitis B virus, he almost jumped for joy.

Because this means that the damn hepatitis B disease can really be solved.

At this time, he was very grateful to Raymond Lam, thanking Raymond Lam for giving him a second life and thanking Raymond Lam for saving his family.

However, there is still one problem that has not been solved, which is how much the "Xingtu EBT-107 Hepatitis B Gene Medical Drug" costs.

After all, the savings of his family and both sets of parents had been emptied half a year ago, and after he gave up treatment, he worked desperately for several months.

However, if you use the money while accumulating savings, the savings accumulated in a few months will not exceed 1 yuan.

If the price of 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' is very expensive at this time, it will undoubtedly completely destroy their family's hopes.

In this regard, Lin Feng in the video introduced some other aspects of the 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' and soon came to the price disclosure link.

"Okay, let me announce the price of 'Xingtu EBT-107 Hepatitis B Gene Medical Drug'."

As Lin Feng spoke, the video screen suddenly changed to a price introduction screen.

In this price introduction screen, the price displayed is 1.2 yuan before medical insurance.

Seeing this price, many people's lips twitched. They never expected that Xingtu Technology's medicine would increase in price.

The price has increased directly from an average of 1 yuan to 1.2 yuan, a full increase of 2000 yuan. It can be said that the increase is quite large.

However, compared with another hepatitis B specific drug, Xia Fanning, the price of Xingtu Technology is still quite affordable.

After all, the price of another hepatitis B specific drug, Xia Fanning, is 21660 yuan, which is simply not affordable for ordinary families.

And that 21660 yuan is just the price of a bottle of Xiafanning. In fact, it will take at least three months for YC to turn from positive to negative.

This means that the total expenditure for three bottles in three months is 6.4 yuan. This price is directly beyond the reach of many families because many families do not have so much savings.

Now a bottle of 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' only costs 1.2 yuan, which is still quite affordable and acceptable.

Of course, they didn't stay happy for long, because this only represented the price of one bottle, and no one knew how many bottles would be injected.

So they read the subsequent introduction and found that 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' was the same as 'EBT-002 Gene Medical Drug'.

They also need to inject at least two bottles, and whether to continue injecting the third bottle depends on whether there is still hepatitis B virus in the body. In response to this, hepatitis B patients on the Internet have begun to calculate the price.

I found that the price of the medicine was only between 2.4 and 3.6 yuan. After deducting medical insurance, I only had to pay a few percent of the price, which was still within an acceptable range.

At least it is nearly half the price of another hepatitis B specific drug, Xia Fanning.

And it dares to guarantee that only two to three bottles are needed to eliminate the hepatitis B virus, and finally, the treatment time only takes a few days.

Overall, Xingtu Gene's "Xingtu EBT-107 Hepatitis B Gene Medical Drug" is superior to Gilead's Xia Fanning in all aspects.

If people are given the opportunity to choose, they will definitely give priority to using 'Xingtu EBT-107 Hepatitis B Gene Medical Drug'.

After all, the 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' can ensure % elimination of the hepatitis B virus, but the other Xia Fan would rather not guarantee it.

Finally, considering that Xia Fanning is so expensive and the treatment time is as long as three months, those hepatitis B patients will naturally vote with their feet and choose "Xingtu EBT-107 Hepatitis B Gene Medical Drug".

So as the prices were revealed, those hepatitis B patients knew who to choose.

On the other hand, when the hepatitis B patients or their families were extremely excited, Lin Feng in the video continued:

"The 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' we developed does not modify human genes, but only kills the hepatitis B virus, which greatly improves its safety.

Therefore, the Daxia Medical Office has expedited the approval of the clinical trial application and is about to begin clinical trials.

It is expected that our 'Xingtu EBT-107 Hepatitis B Gene Medical Drug' will be on the market in about one or two months.

So, to all the patients around the world who are suffering from hepatitis B, please hold on for another month or two and don't give up hope of life.

As for overseas countries, we have also submitted clinical trial application documents. We hope that the medical authorities of various countries can expedite the approval of clinical trial applications and then put the product on the market earlier.

After all, 130 million people die from hepatitis B virus every year around the world, which means one person dies from hepatitis B virus every 30 seconds.

Here, I sincerely hope that the medical authorities in overseas countries can expedite the approval of clinical trial applications.

Don't be like the AIDS specific drug 'EBT-002 gene medical drug', more than three months have passed.

As a result, the clinical trial has not been approved yet, and the date of its launch on the market is nowhere in sight.

I have absolutely no idea why they are not approving the clinical trial application, if it is because of concerns about safety.

In the past three months, a total of 900 million people around the world have been injected with the 'EBT-002 gene medical drug' in our country, and there has not been a single death case among them. What do they have to worry about?

If there really are any side effects, three months would be enough to show them up. Aren’t 900 million samples enough?

As for the problem that the efficacy of the 'RNP complex' will gradually decrease over time after being transported over a long distance.

We can choose a country near each major state to build a production plant, so that nearby patients can obtain the 'EBT-002 gene medical drug' through expedited air transportation channels.

Therefore, the only factor is that the overseas launch of the 'EBT-002 gene medical drug' was hindered by political or profit reasons!

Here, I sincerely hope that some people overseas can go to the hospital to see those patients suffering from illness and hear their pain and bitterness.

Stop disregarding human lives and ignoring people’s grief for a small amount of money.

(End of this chapter)